Eudaimonia Partners, LLC Edwards Lifesciences Corp Transaction History

Eudaimonia Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $281,001 - $353,705	-2,756 Closed	0 $0
Q3 2021 Oct 25, 2021	BUY	$102.91 - $122.75 $63,186 - $75,368	614 Added 28.66%	2,756 $312,000
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $15,678 - $19,590	187 Added 9.57%	2,142 $222,000
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $8,261 - $9,520	105 Added 5.68%	1,955 $164,000
Q4 2020 Feb 18, 2021	SELL	$71.69 - $91.23 $286 - $364	-4 Reduced 0.22%	1,850 $168,000
Q3 2020 Nov 23, 2020	SELL	$67.19 - $87.44 $34,199 - $44,506	-509 Reduced 21.54%	1,854 $148,000
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $82,576 - $107,463	1,229 Added 108.38%	2,363 $115,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $28,079 - $37,551	488 Added 75.54%	1,134 $78,000
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $1,834 - $2,835	-35 Reduced 5.14%	646 $122,000
Q4 2019 May 05, 2020	BUY	$71.7 - $82.09 $48,827 - $55,903	681 New	681 $159,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.